We use tools, such as cookies, to enable essential services and functionality on our site. We also use this to collect data on how our visitors interact with our site, products and services. By clicking accept, you agree to our use of these tools for advertising, analytics and support. I Accept Privacy Policy Cookie Policy

immunodiagnosticsystems
0
immunodiagnosticsystems
0
  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
    • IDS Values
    • Careers
    • News and Events
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    CKD-MBD
    Growth
    Cartilage Markers
    Reproductive
    Autoimmunity
    Infectious Diseases
    Allergy
    Covid-19
    Sarcoidosis Assays
    Therapeutic Drug Monitoring
    Endocrine Hypertension
    Adrenal Function
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • COVID-19 Tests
  • Investor Relations
  • Contact
immunodiagnosticsystems
+44 (0)191 5190660
0

Quotes

  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
    • IDS Values
    • Careers
    • News and Events
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    CKD-MBD
    Growth
    Cartilage Markers
    Reproductive
    Autoimmunity
    Infectious Diseases
    Allergy
    Covid-19
    Sarcoidosis Assays
    Therapeutic Drug Monitoring
    Endocrine Hypertension
    Adrenal Function
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • COVID-19 Tests
  • Investor Relations
  • Contact

Month: December 2009

  • All News
  • Company News
  • Event News
  • Industry News
  • Product News
Group of people holding a meeting in an office space

Director / PDMR Shareholding

Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, has been informed today that the stepson of Paul Hailes, Finance Director, has sold 1,350 ordinary shares of 2p in the Company at a price of 677.15 pence. The shares were held in Paul Hailes’ name as his stepson was under the […]

Group of people holding a meeting in an office space

Share Options November 17th 2009

Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 17 November 2009, 108,446 ordinary shares of 2p each in the Company (the “Ordinary Shares”) were allotted in a board meeting to satisfy an exercise of options. Application will be made at the earliest practicable opportunity for admission of […]

Leaves against a sunny sky

Appointment of Non-Executive Director – Patrik O Dahlen

Immunodiagnostic Systems Holdings plc (“IDS”), a leading producer of diagnostic testing kits for the clinical and research markets, announces the appointment of Dr. Patrik O Dahlén as a Non-Executive Director with immediate effect. Download Announcement

Two IDS members inspect assays

Share Options December 9th 2009

Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 9 December 2009, certain Directors exercised options over in aggregate 1,134,297 ordinary shares of 2p each in the Company (“Ordinary Shares”) and subsequently placed 505,628 ordinary shares in aggregate with a number of institutional investors. Notification was received by […]

  • About Us
  • Products
  • Instrumentation
  • Clinical Areas
  • Research Areas
  • Investor Relations
  • Contact
Connect with us
Connect with us
Connect with us
  • Careers
  • News & Events
  • Sitemap
  • Cookie Policy
  • Terms of Use Policy
  • Privacy Policy
  • Acceptable Use Policy
  • Purchasing T&Cs
  • Terms of Sale
IDS PLC © 2021 Immunodiagnostic Systems. All Rights Reserved. IDS is a listed company, traded on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. Please note our sites uses cookies for content personalisation, please review our cookie policy for further information.

To receive our Newsletter Document Name, please provide us with your following details:

To receive our Newsletter, please provide us with your following details: